Global Cell Banking Outsourcing Market Growth (Status and Outlook) 2025-2031

Global Cell Banking Outsourcing Market Growth (Status and Outlook) 2025-2031

The global Cell Banking Outsourcing market size is predicted to grow from US$ 9168 million in 2025 to US$ 24420 million in 2031; it is expected to grow at a CAGR of 17.7% from 2025 to 2031.

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.

North America is the largest Cell Banking Outsourcing market with about 38% market share. Europe is follower, accounting for about 22% market share.The key manufacturers are SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell etc. Top 3 companies occupied about 13% market share.

LPI (LP Information)' newest research report, the “Cell Banking Outsourcing Industry Forecast” looks at past sales and reviews total world Cell Banking Outsourcing sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Banking Outsourcing sales for 2025 through 2031. With Cell Banking Outsourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Banking Outsourcing industry.

This Insight Report provides a comprehensive analysis of the global Cell Banking Outsourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Banking Outsourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Banking Outsourcing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Banking Outsourcing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Banking Outsourcing.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Banking Outsourcing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Stem Cell Banking
Non-stem Cell Banking

Segmentation by Application:
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell